Top Markets
Coin of the day
China Biotech Services Holdings Limited China Biotech Services Holdings Limited

China Biotech Services Holdings Limited

8037
Clasificación en acciones #23175
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech... Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
Precio por acción
$0.07931426
Última sincronización: 2026-08-21
Capitalización bursátil
$77.39M
Cambio (1 día)
0.81%
Cambio (1 año)
-49.20%
País
HK
Comercio China Biotech Services Holdings Limited (8037)

Categoría

Ratio P/E de China Biotech Services Holdings Limited (8037)
Ratio P/E al 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de China Biotech Services Holdings Limited, el P/E actual (TTM) de la empresa es 0. Al final de 2026, la empresa tenía un P/E de 0.
Historial del ratio P/E de China Biotech Services Holdings Limited desde 2026 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
Not enough data for the provided dates.
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
31.59 -
US
35.83 -
US
- -
CN
-227.89 -
US
29.77 -
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.